Lexiva

Drug Details

Fosamprenavir, marketed as Lexiva, is a medication used as part of an antiretroviral therapy regimen to manage HIV infection. It functions by reducing the amount of HIV in the body, thereby aiding the immune system's effectiveness and decreasing the likelihood of HIV-related complications, such as infections and cancer. This contributes to an improved quality of life for individuals with HIV. Fosamprenavir belongs to a group of medications known as protease inhibitors, which work by blocking the protease enzyme. This enzyme is crucial for the HIV virus to process viral proteins and infect healthy cells. By inhibiting this enzyme, fosamprenavir prevents the virus from replicating and spreading. The medication is typically administered twice daily and often used in conjunction with a "booster" like ritonavir (Norvir) to enhance its efficacy. While fosamprenavir is no longer the first-choice treatment due to potential side effects such as rash, diarrhea, and nausea, it can still be an integral part of an HIV treatment plan. It is important to adhere to all prescribed medications and use protective measures, such as condoms, to minimize the risk of transmitting the virus to others. Fosamprenavir is not a cure for HIV, and patients should follow their healthcare provider's instructions closely, including not sharing personal items that could transmit bodily fluids. Always consult with a healthcare professional before starting or changing any medication regimen.